| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $439.2M | +7.8% | +3.9% |
| Cost of Revenue | $81.0M | -0.4% | -0.8% |
| Gross Profit | $358.2M | +9.9% | +5.1% |
| R&D Expense | $85.4M | -3.3% | +6.3% |
| SG&A Expense | $47.3M | -17.6% | +5.8% |
| Operating Income | $60.9M | — | +19.5% |
| Income Tax | $45.1M | +246.2% | +53.3% |
| Net Income | $4.0M | +186.0% | +128.6% |
| EPS (Basic) | $0.01 | +150.0% | +120.0% |
| EPS (Diluted) | $0.01 | +150.0% | +120.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.35B | +28.2% | +44.7% |
| Short-term Investments | $122.7M | -50.2% | -60.1% |
| Accounts Receivable | $328.2M | -1.3% | +17.6% |
| Current Assets | $2.05B | +5.7% | +11.1% |
| Total Assets | $5.30B | +0.8% | +2.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $327.5M | — | — |
| Capital Expenditures | $6.5M | — | — |
| Investing Cash Flow | $200.6M | — | — |
| Financing Cash Flow | -$118.2M | — | — |
| Free Cash Flow | $321.0M | — | — |
| $946.2M |
| -1.6% |
| +11.7% |
| Long-term Debt | $1.80B | -0.2% | -0.8% |
| Total Liabilities | $2.85B | -0.8% | +3.0% |
| Stockholders' Equity | $2.45B | +2.7% | +1.7% |